Diabetes

Patients with diabetes receiving insulin treatment with lower cost sharing for blood glucose testing strips were more likely to achieve glycemic control than those with higher cost sharing.

Flatiron Health expects to maintain its current business model in the transaction.

The study used a claims database to examine records from patients who switched between long-acting insulins.

Language in the new government budget ensures effective changes to CMS' Competitive Bidding Program for diabetes testing supplies that will benefit patients with diabetes.

Such a large drop in Americans' sense of well-being in their daily lives in a time of economic good fortune is unprecedented, index organizers say.

Of the 262 patients with type 2 diabetes in the intervention, 83% stuck with it through the first year, despite significant requirements.

An individual’s body mass index (BMI) can increase when exposed to counties with a higher prevalence of obesity, according to a study published in JAMA Pediatrics.

Despite an official policy since early 2017 that calls for Medicare to cover CGM for certain beneficiaries with diabetes, an attorney who won a landmark case prior to the policy change reports that beneficiaries are still being denied coverage.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included President Donald Trump vowing to lower drug prices during his State of the Union address; 3 corporate giants joined forces on healthcare; and CAR T-cell therapy was named the cancer advance of the year.

Empagliflozin (Jardiance) and another SGLT2 inhibitor, canagliflozin (Invokana) have been competing aggressively; both have clinical trial results showing cardiovascular benefits.

Officials at Omada Health said the PREDICTS trial was planned long before CMS decided not to include virtual providers in this spring's launch of the Medicare Diabetes Prevention Program. But a spokesperson said the company hopes the growing body of evidence in support of virtual programs will "assuage any concerns."

The pairing will give employers and health plans "holistic" solutions for chronic disease management, according to CEOs of the companies.

Racial/ethnic minorities and patients living in poorer neighborhoods were more likely to access their personal health record exclusively with a mobile device.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care stories included CMS unveiling a new voluntary bundled payment model; coverage from the JP Morgan Healthcare Conference, including immunotherapy's impact on HIV treatment and biosimilars; and news that 2 key diabetes devices will be covered by Medicare.

The same mechanisms that cause those with long-term HIV infection to suffer higher rates of heart attacks or strokes put children born with disease at early risk of cardiovascular disease, according to a new study.

This week, the investors and analysts turned their attention to presentations by business leaders at the 36th Annual JP Morgan Healthcare Conference, held in San Francisco, California. Executives from the pharmaceutical and healthcare worlds showcased their products, pipelines, and visions for the future.

Older adults who are prescribed many medications that require frequent trips to the pharmacy are more likely to not refill their prescriptions on time, but patients who participate in medication synchronization programs have improved adherence to cardiovascular medications, according to a study published in Health Affairs.

Brenda Schmidt, CEO of Solera Health, discusses the historic launch of the Medicare Diabetes Prevention Program scheduled for this April and how her company is helping providers and other stakeholders get ready.

Brenda Schmidt is CEO of Solera Health, an integrator that serves as the “back office” for both community-based and digital providers of the Diabetes Prevention Program (DPP), an evidence-based program that has been shown to reduce incidence of people with prediabetes progressing to type 2 diabetes. In April, Medicare will take the historic step of launching the DPP for beneficiaries, and Solera has been at the forefront of helping providers navigate the policy and technical hurdles to serve clients who will take part in the DPP.

The factory-calibrated continuous glucose monitoring (CGM) system is being touted as less expensive, and a spokeswoman said it will not require bundling with a meter, which is required for a competitor.

Dexcom Executive Vice President and Chief Commercial Officer RIck Doubleday visited The American Journal of Managed Care® to discuss Medicare reimbursement for the Dexcom G5 and a new partnership with Fitbit.